Cardiol Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21.42	30.58	34.93	59.47	83.9
Cash & Short-Term Investments	21.42	30.58	34.93	59.47	83.9
Cash Growth	-29.97%	-12.46%	-41.26%	-29.12%	498.20%
Accounts Receivable	-	-	-	-	0.07
Other Receivables	0.23	0.36	0.28	0.48	0.34
Receivables	0.23	0.36	0.28	0.48	0.41
Prepaid Expenses	1.86	0.73	0.94	1.49	2.83
Total Current Assets	23.5	31.67	36.15	61.44	87.14
Property, Plant & Equipment	0.12	0.2	0.34	0.3	0.36
Other Intangible Assets	-	-	0.21	0.29	0.38
Total Assets	23.62	31.86	36.7	62.03	87.88
Accounts Payable	3.48	6.98	7.62	8.35	4.14
Accrued Expenses	-	-	0.42	0.99	0.72
Current Portion of Leases	0.04	0.03	0.02	0.05	0.04
Other Current Liabilities	2.14	-	0.24	0.42	6.66
Total Current Liabilities	5.66	7.01	8.3	9.8	11.57
Long-Term Leases	0.09	0.13	0.16	0.02	0.07
Total Liabilities	5.74	7.14	8.45	9.83	11.64
Common Stock	201.87	179.34	148.52	147.55	142.92
Additional Paid-In Capital	29.08	24.65	18.79	15.59	12.66
Retained Earnings	-213.07	-179.25	-142.58	-114.45	-83.52
Comprehensive Income & Other	-	-	3.52	3.52	4.18
Shareholders' Equity	17.88	24.73	28.25	52.2	76.24
Total Liabilities & Equity	23.62	31.86	36.7	62.03	87.88
Total Debt	0.13	0.16	0.17	0.07	0.12
Net Cash (Debt)	21.29	30.42	34.76	59.4	83.78
Net Cash Growth	-30.01%	-12.47%	-41.48%	-29.10%	504.11%
Net Cash Per Share	0.24	0.43	0.54	0.95	1.94
Filing Date Shares Outstanding	97.94	82.61	68.27	64.1	61.93
Total Common Shares Outstanding	97.94	82.61	65.35	64.04	61.92
Working Capital	17.85	24.66	27.86	51.63	75.58
Book Value Per Share	0.18	0.30	0.43	0.82	1.23
Tangible Book Value	17.88	24.73	28.04	51.91	75.86
Tangible Book Value Per Share	0.18	0.30	0.43	0.81	1.23
Machinery	-	0.39	0.42	0.35	0.28
Leasehold Improvements	-	0.24	0.24	0.24	0.24

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.